C.H. Robinson Worldwide, Inc. entered into a definitive merger agreement to acquire RXO, Inc. in an all-stock and cash transaction valued at approximately $5.8 billion in enterprise value. Under the terms of the deal, RXO shareholders will receive $17.25 in cash plus 0.0856 shares of C.H. Robinson common stock for each share held, representing a total implied consideration of $30.25 per share. The transaction is expected to close in the first half of 2027, subject to customary closing conditions including regulatory approvals and RXO shareholder consent. C.H. Robinson has secured a $4.5 billion bridge facility from Morgan Stanley Senior Funding, Inc., to finance the cash portion of the consideration. The combined entity is projected to generate approximately $300 million in net run-rate cost synergies within two years post-close.
